Upgrade to SI Premium - Free Trial

Eloxx Pharmaceuticals (ELOX)

17.20 +0.90 (5.52%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form S-1 Eloxx Pharmaceuticals, September 11, 2026 5:29 PM - SEC Filing Eloxx doses first patients in Phase 2b Alport syndrome trial September 11, 2026 7:30 AM - StreetInsider Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome September 11, 2026 7:30 AM - PR NewsWire Lucid Capital Markets Starts Eloxx Pharma (ELOX) at Buy August 20, 2026 6:05 AM - StreetInsider Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Samsara BioCapital, L.P. August 14, 2026 4:54 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Nantahala Capital Management, LLC August 14, 2026 4:44 PM - SEC Filing Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update August 12, 2026 6:00 AM - PR NewsWire Form 8-K Eloxx Pharmaceuticals, For: Aug 11 August 11, 2026 5:20 PM - SEC Filing Form 10-Q Eloxx Pharmaceuticals, For: Jun 30 August 11, 2026 5:03 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Aberdeen Group plc July 27, 2026 7:56 AM - SEC Filing LifeSci Capital Starts Eloxx Pharma (ELOX) at Outperform July 22, 2026 7:54 AM - StreetInsider Guggenheim Starts Eloxx Pharma (ELOX) at Buy July 20, 2026 2:50 AM - StreetInsider Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Coastlands Capital LP June 17, 2026 7:16 PM - SEC Filing Form SCHEDULE 13G Eloxx Pharmaceuticals, Filed by: Domicilium Real Estate Fund III LP June 17, 2026 5:18 PM - SEC Filing Form 4 Eloxx Pharmaceuticals, For: Jun 10 Filed by: Domicilium Real Estate Fund III LP June 17, 2026 5:15 PM - SEC Filing Form 3 Eloxx Pharmaceuticals, For: Jun 05 Filed by: Domicilium Real Estate Fund III LP June 17, 2026 5:11 PM - SEC Filing Full Article List